Literature DB >> 29536301

Expression Profiles of Genes-Potential Therapy Targets-and Their Relationship to Survival in Renal Cell Carcinoma.

N V Apanovich1, M V Peters2, P V Apanovich1, B Sh Kamolov2, V B Matveev2,3, E K Ginter1, A V Karpukhin4.   

Abstract

The main mechanisms of pathogenesis of clear cell renal cell carcinoma (CCRCC) are realized through the PI3K-AKT-mTOR and Ras-RAF-ERK signaling pathways. Targeted therapy is directed primarily at the genes and their encoded products that are components of these pathways. The levels of expression and coexpression of target genes were determined, and the difference in the functioning of the genes of one of the two major signaling pathways in tumors of CCRCC patients with different life duration (more and less than 3.5 years) and the relationship of the VEGFA gene expression level with the life duration was revealed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29536301     DOI: 10.1134/S1607672918010040

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  8 in total

1.  Novel agents in renal carcinoma: a reality check.

Authors:  Yana G Najjar; Brian I Rini
Journal:  Ther Adv Med Oncol       Date:  2012-07       Impact factor: 8.168

2.  Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.

Authors:  Masabumi Shibuya
Journal:  Genes Cancer       Date:  2011-12

3.  Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

Authors:  Arkaitz Carracedo; Li Ma; Julie Teruya-Feldstein; Federico Rojo; Leonardo Salmena; Andrea Alimonti; Ainara Egia; Atsuo T Sasaki; George Thomas; Sara C Kozma; Antonella Papa; Caterina Nardella; Lewis C Cantley; Jose Baselga; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

4.  BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks.

Authors:  Jonas Richiardi; Andre Altmann; Anna-Clare Milazzo; Catie Chang; M Mallar Chakravarty; Tobias Banaschewski; Gareth J Barker; Arun L W Bokde; Uli Bromberg; Christian Büchel; Patricia Conrod; Mira Fauth-Bühler; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Hervé Lemaître; Karl F Mann; Jean-Luc Martinot; Frauke Nees; Tomáš Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Rainer Spanagel; Andreas Ströhle; Gunter Schumann; Mike Hawrylycz; Jean-Baptiste Poline; Michael D Greicius
Journal:  Science       Date:  2015-06-11       Impact factor: 47.728

5.  Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.

Authors:  Frédéric Reynier; Fabien Petit; Malick Paye; Fanny Turrel-Davin; Pierre-Emmanuel Imbert; Arnaud Hot; Bruno Mougin; Pierre Miossec
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

Review 6.  The mTOR signalling pathway in human cancer.

Authors:  Helena Pópulo; José Manuel Lopes; Paula Soares
Journal:  Int J Mol Sci       Date:  2012-02-10       Impact factor: 6.208

7.  Targeted Therapy for Metastatic Renal Carcinoma: an Update.

Authors:  Rodrigo Donalisio da Silva; Diedra Gustafson; Leticia Nogueira; Priya N Werahera; Wilson R Molina; Fernando J Kim
Journal:  J Kidney Cancer VHL       Date:  2014-10-21

8.  Vascular endothelial growth factor can signal through platelet-derived growth factor receptors.

Authors:  Stephen G Ball; C Adrian Shuttleworth; Cay M Kielty
Journal:  J Cell Biol       Date:  2007-04-30       Impact factor: 10.539

  8 in total
  3 in total

Review 1.  Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.

Authors:  Simona Mihai; Elena Codrici; Ionela Daniela Popescu; Ana-Maria Enciu; Lucian Albulescu; Laura Georgiana Necula; Cristina Mambet; Gabriela Anton; Cristiana Tanase
Journal:  J Immunol Res       Date:  2018-09-06       Impact factor: 4.818

2.  FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.

Authors:  Qi Lv; Gangmin Wang; Yinan Zhang; Xiao Han; Haoming Li; Wei Le; Minguang Zhang; Chunhui Ma; Peijun Wang; Qiang Ding
Journal:  Int J Oncol       Date:  2019-02-22       Impact factor: 5.650

3.  Radix Actinidia chinensis Suppresses Renal Cell Carcinoma Progression: Network Pharmacology Prediction and In Vivo Experimental Validation.

Authors:  Biao Liu; Liang Zhang
Journal:  Anal Cell Pathol (Amst)       Date:  2022-07-30       Impact factor: 4.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.